Skip to content

Tinaquant Complement C3c ver2 3001938322

by Roche Diagnostics GmbH

Tinaquant Complement C3c ver2 3001938322 is a Class II device made by Roche Diagnostics GmbH, cleared under FDA 510(k) K012361 on 29 Nov 2001 and listed in FDA GUDID since 20 Sep 2016 (UDI-DI 04015630917709), active as of 12 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 12 Nov 2026

Documents

510(k) K012361

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 12 Nov 2026.

Regulatory status

as of registry sync 12 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number04015630917709 UDI-DI Date20 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK012361 Date29 Nov 2001DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K012361 decided 29 Nov 2001 Active
  • FDA GUDID UDI-DI 04015630917709 listed 20 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K012361
  2. Listed FDA GUDID 04015630917709

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Tinaquant Complement C3c ver2
Generic name
Complement components C3/C3c IVD, kit, nephelometry/turbidimetry
Model / Ref / Catalog
3001938322
Primary DI / UDI-DI
04015630917709
510(k) Number
FDA product code
CZW
GMDN term
Complement components C3/C3c IVD, kit, nephelometry/turbidimetry
Device class
Class II
Regulation number
866.5240
GUDID distribution status
In Commercial Distribution

Other devices from Roche Diagnostics GmbH

See all devices from Roche Diagnostics GmbH →

Properties

  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)